Skip to search formSkip to main contentSkip to account menu

fondaparinux

Known as: fondaparinux [Chemical/Ingredient] 
A synthetic glucopyranoside with antithrombotic activity. Fondaparinux selectively binds to antithrombin III, thereby potentiating the innate… 
National Institutes of Health

Related topics

Related topics

18 relations
0.6 ML Fondaparinux sodium 12.5 MG/ML Prefilled Syringe [Arixtra]0.8 ML Fondaparinux sodium 12.5 MG/ML Prefilled SyringeBacterial EndocarditisDrug Allergy

Broader (2)

AnticoagulantsPolysaccharides

Narrower (1)

Arixtra

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Antithrombin is protective against myocardial ischemia and reperfusion injury
Antithrombin (AT) is a plasma serpin inhibitor that regulates the proteolytic activity of procoagulant proteases of the clotting… 
Review
2012
Review
2012
Current guidelines for total joint VTE prophylaxis: dawn of a new day.
Venous thromboembolism (VTE) remains an immediate threat to patients following total hip and knee replacement. While there is a… 
Review
2008
Review
2008
The Approach to Heparin-Induced Thrombocytopenia
t t t t 
2007
2007
Prevention and treatment of experimental thrombosis in rabbits with rivaroxaban (BAY 597939) – an oral, direct factor Xa inhibitor
Summary Current anticoagulant therapies for the prevention and treatment of thromboembolic disorders have many drawbacks: vitamin… 
Review
2007
Review
2007
Fondaparinux as a Treatment Option for Heparin‐Induced Thrombocytopenia
Heparin‐induced thrombocytopenia (HIT) is an immune‐mediated complication that can occur after exposure to heparin products… 
Review
2005
Review
2005
Synthetic heparin derivatives as new anticoagulant drugs.
Highly Cited
2004
Highly Cited
2004
Treatment of heparin-induced thrombocytopenia with fondaparinux.
Anticoagulation of patients with heparin-induced thrombocytopenia (HIT) may be limited by cross-reaction of HIT antibodies with… 
Highly Cited
2004
Highly Cited
2004
Fondaparinux: a suitable alternative in cases of delayed‐type allergy to heparins and semisynthetic heparinoids? A study of 7 cases
Hypersensitivity to unfractionated and low‐molecular‐weight heparins and semisynthetic heparinoids is increasingly common. 7… 
Highly Cited
2003
Highly Cited
2003
Fondaparinux (ARIXTRA) as an alternative anti-thrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins.
During the last decade, new anticoagulant drugs with anti-factor-Xa properties have been described (1, 2). Among them is… 
Review
2003
Review
2003
Short‐ and long‐acting synthetic pentasaccharides
Abstract Koopman MMW, Büller HR (Academic Medical Centre, Amsterdam, The Netherlands). Short‐ and long‐acting synthetic… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)